Moonlight Therapeutics is an early-stage biotechnology company developing targeted, allergen-specific immunotherapy treatments for food allergies. Food allergies are estimated to affect more than 30 million people in the United States. Moonlight uses its proprietary platform, TASIS, to target the delivery of allergens to immune cells in the skin.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/31/21 | undisclosed |
SeedtoB Capital | undisclosed |
